Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, R. Donald Harvey, John Kauh et al.|Clinical Cancer Research|2015Cited by 168
Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patientsRebecca Evans, Emmanuel Mignot, Haruhide Kimura et al.|Proceedings of the National Academy of Sciences|2022Cited by 92